+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hunter Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hunter Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chronic Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Angelman Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Angelman Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypofibrinogenemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypofibrinogenemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2025 - Product Thumbnail Image

Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Genital Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Genital Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2025 - Product Thumbnail Image

Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Mineral Metabolism Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Mineral Metabolism Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Erosive Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Diverticulitis - Pipeline Insight, 2025 - Product Thumbnail Image

Diverticulitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Niemann Pick C Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Niemann Pick C Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cerebral Amyloid Angiopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Cerebral Amyloid Angiopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Meibomian Gland Dysfunction- Pipeline Insight, 2025 - Product Thumbnail Image

Meibomian Gland Dysfunction- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Complicated Intra-Abdominal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Spinal Cord Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rabies Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rabies Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Peripheral Nerve Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Nerve Injuries - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more